Modulators of CFTR. Updates on clinical development and future directions
Emmanuelle Bardin(Centre National de la Recherche Scientifique), Isabelle Sermet‐Gaudelus(Hôpital Necker-Enfants Malades), Alexandra Pastor(Centre National de la Recherche Scientifique), B. Chevalier(Jackson Laboratory), Guillaume Prestat(Centre National de la Recherche Scientifique), Anita Golec(Inserm), Iwona Pranke(Centre National de la Recherche Scientifique), Christine Gravier‐Pelletier(Centre National de la Recherche Scientifique), Farouk Berhal(Centre National de la Recherche Scientifique), Michaëla Semeraro(Inserm), Kate Hayes(Cystic Fibrosis Ireland), Alexandre Hinzpeter(Inserm)
Cited by 67
Related Papers
Cloning and variation of ground state intestinal stem cells
|Nature|2015|200
<i>Pseudomonas aeruginosa</i>infection in cystic fibrosis: pathophysiological mechanisms and therapeutic approaches
|Expert Review of Respiratory Medicine|2016|170
<i>Mycobacterium abscessus</i>and Children with Cystic Fibrosis
|Emerging infectious diseases|2003|159
Current and future therapies for Pseudomonas aeruginosa infection in patients with cystic fibrosis
|FEMS Microbiology Letters|2017|107